Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

Por McGurnaghan, S., Blackbourn, L. A. K., Mocevic, E., Haagen Panton, U., McCrimmon, R. J., Sattar, N., Wild, S., Colhoun, H. M.
Publicado no Diabet Med (2018)

Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes

Por Fan, X., Ding, Y., Brown, S., Zhou, L., Shaw, M., Vella, M. C., Cheng, H., McNay, E. C., Sherwin, R. S., McCrimmon, R. J.
Publicado em 2009

Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) proje...

Por de Galan, B. E., McCrimmon, R. J., Ibberson, M., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., Tack, C. J., Müllenborn, M.
Publicado no Diabet Med (2020)

Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour

Por Beall, C., Hamilton, D. L., Gallagher, J., Logie, L., Wright, K., Soutar, M. P., Dadak, S., Ashford, F. B., Haythorne, E., Du, Q., Jovanović, A., McCrimmon, R. J., Ashford, M. L. J.
Publicado em 2012